SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-036522
Filing Date
2019-10-07
Accepted
2019-10-07 08:07:03
Documents
3
Period of Report
2019-10-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngm-8k_20191007.htm 8-K 37636
2 EX-99.1 ngm-ex991_6.htm EX-99.1 42249
3 GRAPHIC gv5wo4ejna0z000001.jpg GRAPHIC 4434
  Complete submission text file 0001564590-19-036522.txt   87243
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38853 | Film No.: 191139659
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences